Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Merck Q2 Earnings in the Cards: Buy, Sell or Hold Ahead of Results?
09:31am, Friday, 25'th Jul 2025
MRK is gearing up to report Q2 earnings. While Keytruda drives growth, there are concerns over Gardasil's China sales, generics and pipeline depth.
The U.S. Keytruda market, valued at $17.87 billion in 2024, faces a projected CAGR decline of -3.12% by 2033 due to patent expiration and biosimilar competition. Keytruda's continued use in various ca
Exploring Analyst Estimates for Merck (MRK) Q2 Earnings, Beyond Revenue and EPS
10:16am, Thursday, 24'th Jul 2025
Beyond analysts' top-and-bottom-line estimates for Merck (MRK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter end
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 24'th Jul 2025
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
How to Build a Super Low Cost Passive Income Fund for Only $25,000
04:10pm, Wednesday, 23'rd Jul 2025
Key Points The RSPA ETF will immediately turn the bulk of your $25,000 account into a diversified income machine. Smaller allocations into SCHD, JEPQ, and FDVV will help you build a low-fee passive in
Will Keytruda Continue to Aid MRK's Top Line Ahead of Q2 Earnings?
11:26am, Wednesday, 23'rd Jul 2025
Merck's Keytruda drives nearly half of its pharma sales. Investors eye Q2 momentum amid existing competition.
Dow Leads as Health Care Stocks Merck and Amgen Gain: Stock Market Today
04:07pm, Tuesday, 22'nd Jul 2025
Second-quarter earnings season remained top of mind Tuesday, with Coca-Cola and GM among those reporting.
Merck Announces Fourth-Quarter 2025 Dividend
11:53am, Tuesday, 22'nd Jul 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Fourth-Quarter 2025 Dividend.
Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for
11:07am, Tuesday, 22'nd Jul 2025
Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'
09:18am, Tuesday, 22'nd Jul 2025
Initiating Rapid Micro Biosystems at 'buy' with $4.60 fair value, driven by strong growth potential in automated microbial quality control market. Growth Direct platform offers clear advantages over m
Merck Commits to Veeva Vault CRM
10:00am, Monday, 21'st Jul 2025
Deep application provides foundation for commercial execution PLEASANTON, Calif. , July 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known as MSD outside
Does This Move Make Merck Stock a Buy?
09:50am, Sunday, 20'th Jul 2025
Merck (MRK -1.91%), a leading pharmaceutical company, generates consistent revenue and profits. However, the stock has been under pressure over the past year due to its reliance on Keytruda, its famou
Should You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?
09:25am, Sunday, 20'th Jul 2025
One of the big reasons to like Pfizer (PFE -0.47%) today is its huge 7.1% dividend yield. To put that yield into context, the S&P 500 index is yielding roughly 1.3% and the average healthcare stock a
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Merck (MRK) To Contact Him Directly To Discuss Their Options
Got $200? 2 Dividend Stocks to Buy and Hold Forever
05:40am, Saturday, 19'th Jul 2025
The science that backs healthcare breakthroughs is mind-bogglingly complex. If you don't specialize in the medical space, you should probably avoid small, research-driven healthcare stocks.
